May 2026
The global Alzheimers disease diagnostics market size was evaluated at USD 9.40 billion in 2025 and is predicted to hit around USD 26.21 billion by 2035, growing at a CAGR of 10.80%.
May 2026
The infectious respiratory disease diagnostics market size is projected to hit around USD 96.57 billion by 2035 from USD 57.55 billion in 2025 with a CAGR of 5.31%.
March 2026
The global infectious disease diagnostics market size is expected to reach around USD 71.06 billion by 2035 from USD 35.39 billion in 2025 with a CAGR of 7.22%.
January 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.10 billion in 2025 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
January 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
November 2025
The global sexually transmitted diseases diagnostics market size is estimated to hit around USD 21.44 billion by 2034 from USD 11.43 billion in 2025, with a CAGR of 7.24%.
July 2025
The global in-vitro inflammatory bowel disease diagnostics market size was valued at USD 1.74 billion in 2024 and is expected to hit around USD 3.02 billion by 2034, at a CAGR of 5.64%.
July 2025
The global infectious disease molecular diagnostics market size is estimated to hit around USD 63.37 billion by 2034 with a CAGR of 3.25% from 2025 to 2034.
July 2026
The global point-of-care molecular diagnostics market size was valued at USD 8.95 billion in 2025 and is expected to hit around USD 13.06 billion by 2035, at a CAGR of 3.85%.
July 2026
The U.S. tuberculosis diagnostics market size was evaluated at USD 576.00 million in 2025 and is predicted to hit around USD 968.67 million by 2035, growing at a CAGR of 5.34%.
July 2026
The global infectious disease vaccines market size is estimated to hit around USD 77.04 billion by 2035 increasing from USD 38.83 billion in 2025, with a CAGR of 7.09%.
July 2026
The global in vitro diagnostics quality controls market size is estimated to hit around USD 2,713.92 million by 2035, increasing from USD 1,736.17Â million in 2026, with a CAGR of 5.09%.
July 2026
The global tissue diagnostics market size is expected to increase from USD 5.77 billion in 2025 and is projected to hit around USD 10.99 billion by 2035 with a CAGR of 6.66%.
July 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
June 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The global celiac disease treatment market size is evaluated at USD 784.59 million in 2025 and is predicted to hit around USD 2,400.49 million by 2035, growing at a CAGR of 11.83%.
June 2026
The global veterinary point of care diagnostics market size is estimated to hit around USD 7.87 billion by 2035 from USD 2.96 billion in 2025, with a CAGR of 10.27%.
June 2026
The global in vitro diagnostics (IVD) market size accounted for USD 104.01 billion in 2025 and is expected to reach USD 135.76 billion by 2035.
June 2026
The breast cancer diagnostics market size is valued at USD 20.14 billion in 2025 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
June 2026
The global preeclampsia diagnostics market size is evaluated at USD 1.29 billion in 2025 and is predicted to hit around USD 1.75 billion by 2035, growing at a CAGR of 3.10%.
June 2026
The global CRISPR-based diagnostics market size is evaluated at USD 3.79 billion in 2025 and is predicted to hit around USD 17.09 billion by 2035, growing at a CAGR of 16.25%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global minimal residual disease (MRD) testing market size is estimated to hit around USD 5.19 billion by 2035 increasing from USD 1.70 billion in 2025, with a CAGR of 11.81%.
June 2026
The rapid diagnostics market size was estimated at USD 51.12 billion in 2025 and is projected to surpass around USD 322.71 billion in 2035 with a solid CAGR of 20.23%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
June 2026
The global guillain barre syndrome diagnostics market size is estimated to hit around USD 206.70 million by 2035 increasing from USD 154.02 million in 2025, with a CAGR of 2.99%.
June 2026
The global chronic disease management market size was estimated at USD 6.61 billion in 2025 and is expected to hit around USD 23.18 billion by 2035, growing at a CAGR of 13.37% from 2026 to 2035.
June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
June 2026
The global lymphedema diagnostics market size is estimated to hit around USD 73.68 million by 2035, increasing from USD 46.09 million in 2025, with a CAGR of 4.80%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com